Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Sandoz Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (682)
Cancellation by sponsor (321)
Prescription medicine registration (54)
Section 14, TGO91 consent (17)
Cancellation or suspension (8)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)

Date

2024 (82)
2023 (78)
2022 (67)
2021 (121)
2020 (153)
2019 (53)
2018 (60)
2017 (50)
2016 (4)
2015 (39)
2014 (20)
2013 (24)
2012 (13)
2011 (51)
2010 (47)
2009 (37)
2008 (27)
2007 (21)
2006 (21)
2005 (54)
2004 (12)
2003 (10)
2002 (10)
2001 (6)
2000 (5)
1999 (5)
1998 (9)
1997 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

1087 result(s) found, displaying 301 to 310

PIRFENIDONE SANDOZ (Sandoz Pty Ltd)

9 February 2022

Prescription medicine registration

Active ingredients: pirfenidone.
HARMONEX naproxen sodium 275mg tablet blister pack (343457)

14 September 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for HARMONEX naproxen sodium 275mg tablet blister pack.
POMALIDOMIDE SANDOZ (Sandoz Pty Ltd)

23 December 2021

Prescription medicine registration

Active ingredients: pomalidomide.
QUINAPRIL SANDOZ quinapril 5mg (as hydrochloride) film coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

22 December 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
AMIODARONE ACTAVIS amiodarone hydrochloride 100mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

22 December 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
AMIODARONE ACTAVIS amiodarone hydrochloride 200mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

22 December 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
MEPREZE 24 HOUR ONCE DAILY DOSING esomeprazole 20 mg (as esomeprazole magnesium) enteric coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

22 December 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
FLOSIX tamsulosin hydrochloride 400 microgram prolonged release tablet (336015)

3 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FLOSIX tamsulosin hydrochloride 400 microgram prolonged release tablet.
RABEPRAZOLE SZ rabeprazole sodium 20 mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 December 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
RABEPRAZOLE SZ rabeprazole sodium 10 mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 December 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd

Pages

First page
Previous page
…
Page 27
Page 28
Page 29
Page 30
Current page 31
Page 32
Page 33
Page 34
Page 35
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.